Amicus Therapeutics Stock Target Price and Analyst Consensus

FOLD Stock  USD 9.49  0.30  3.26%   
The current analyst and expert consensus on Amicus Therapeutics is Strong Buy, with 8 strong buy opinions. The current projected Amicus Therapeutics target price consensus is 17.09 with 12 analyst opinions. Check out Macroaxis Advice on Amicus Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
The most common way Amicus Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Amicus Therapeutics executives and customers to further validate their buy or sell advice. Amicus Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Amicus Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 2.0103.
Lowest Forecast
15.55
Highest Forecast
18.97
Target Price
17.09
At present, Amicus Therapeutics' Operating Profit Margin is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.94, whereas Pretax Profit Margin is forecasted to decline to (0.06). At present, Amicus Therapeutics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 114.7 M, whereas Total Stockholder Equity is forecasted to decline to about 170.7 M.
  
It's important to approach Amicus Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Amicus Therapeutics Target Price Consensus

Amicus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amicus Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   12  Strong Buy
Most Amicus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amicus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amicus Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Amicus Therapeutics Target Price Projection

Amicus Therapeutics' current and average target prices are 9.49 and 17.09, respectively. The current price of Amicus Therapeutics is the price at which Amicus Therapeutics is currently trading. On the other hand, Amicus Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Amicus Therapeutics Market Quote on 1st of March 2025

Low Price9.14Odds
High Price9.5Odds

9.49

Target Price

Analyst Consensus On Amicus Therapeutics Target Price

Low Estimate15.55Odds
High Estimate18.97Odds

17.0909

Historical Lowest Forecast  15.55 Target Price  17.09 Highest Forecast  18.97
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Amicus Therapeutics and the information provided on this page.

Amicus Therapeutics Analyst Ratings

Amicus Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amicus Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amicus Therapeutics' financials, market performance, and future outlook by experienced professionals. Amicus Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Amicus Therapeutics price targets

Amicus Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Amicus Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Amicus Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amicus Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Amicus Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amicus Therapeutics is a key component of Amicus Therapeutics valuation and have some predictive power on the future returns of a Amicus Therapeutics.
Hype
Prediction
LowEstimatedHigh
7.469.4711.48
Details
Intrinsic
Valuation
LowRealHigh
9.3911.4013.41
Details
Naive
Forecast
LowNextHigh
7.269.2711.28
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.05-0.070.08
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
ESG Investing Idea
ESG Investing
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 30 shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
Banking Idea
Banking
Invested over 30 shares
Blockchain Idea
Blockchain
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Video Games Idea
Video Games
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Robots And Drones Idea
Robots And Drones
Invested over 20 shares
When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:
Check out Macroaxis Advice on Amicus Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Please note, the presentation of Amicus Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amicus Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amicus Therapeutics' management manipulating its earnings.